The Effectiveness of AIFIGA Program on Nursing Home Nursing Staff and Family and Residents'Health
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorChang Gung Memorial Hospital
About this trial
This study aims to develop and evaluate the longitudinal effectiveness of the Artificial Intelligence Family Involvement Generative Agent (AIFIGA) program in enhancing the health of nursing staff, family, and residents' health through the use of a sequential, mixed methods research design. The development of a real-time, interactive, and informative AIFIGA program that sparks innovation is necessary to achieve effective communication between families and nursing staff.
In Phase I, lasting 18 months, we will develop the AIFIGA program based on triangulate research design, observation and in-depth interview understanding the daily communication experiences and expectations from both families and nursing staff perception in Nursing Homes(NHs) after COVID-19, as well as our previous years' research results. The training data for AIFIGA will be derived from the collection of communication dialogues in these qualitative data. Furthermore, the intelligence of AIFIGA will be developed using publicly available large language models (LLMs).
In Phase II, spanning the next 18 months, we will evaluate the longitudinal effects of the AIFIGA program on the health of residents, families, and nursing staff, tracking changes over time (baseline, 1 month, 3 months, and 6 months). There will be two groups of participants: (a) an AIFIGA group that receives the AIFIGA program and uses it for 3 months, and (b) a control group that receives only routine care.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
residents aged ≥ 60 years, resident's family were aged equal or higher than 20 years.
both residents and family can communicate in Mandarin or Taiwanese
residents have a Mini-Mental State Examination (MMSE) score equal to or higher than 16 for residents with no formal education or higher than 24 for residents with at least a primary school education
both residents and family agree to participate
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
AIFIGA program
Behavioralreceives the Artificial Intelligence Family Involvement Generative Agent (AIFIGA) program and uses it for 3 months
Treatment groups
210 Participants
are divided into 2 treatment groupsGroup A: AIFIGA groupExperimental treatment 1 intervention
Group B: control groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
resident health-Geriatric Depression Scale (GDS)
scale for depression( scored from 0 through to 15.Scores of 0-4 are considered normal; 5-8 indicate mild depression; 9-11 indicate moderate depression; and 12-15 indicate severe depression.)
Time frame
baseline, 1 month, 3 months and 6 months2
resident health-Activity of daily living (ADL)
assess individual's ability to perform basic self-care tasks (scored from 0 through to 100. higher scores mean more independence)
Time frame
baseline, 1 month, 3 months and 6 months3
social support scale
Evaluated quantities of social support (four-point Likert scale, where higher scores indicate a greater amount of each type of social resource) \& satisfaction with social support (five-point Likert scale, where higher scores indicate greater satisfaction with social support)
Time frame
baseline4
brief Center for Epidemiological Studies Depression Scale(CESD-10)
assessment for family' depressive status.(scored from 0 through to 30. Any score equal to or above 10 is considered depressed)
Time frame
baseline, 1 month, 3 months and 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov